Equity
€241,797 ▲ 51.3%
IM Medic paid out €154,763 in dividends. That is 65% of the 2025 profit.
IM Medic
Lifetime
5 annual accounts with figures on one time axispeak €316,375 (2025)
€316,375▲ 60.0%
peak €236,797 (2025)
€236,797▲ 53.0%
peak €422,804 (2023)
€241,797▲ 51.3%
€166,573▼ 62.5%
Board1 name since 2021
1 directorMARIEN Ilke Renata Elisabeth
Documentsfilings and deeds
26-06-202635 days before the deadline
2025micro format
Gross margin from €197,778 to €316,375Result from €154,763 to €236,797Dividend €154,763Equity from €159,763 to €241,797Debts from €444,490 to €166,573Cash from €150,745 to €333,763
Key points
from the 2025 annual accountsResult
€236,797 ▲ 53.0%
The result rose in 2025 from €154,763 to €236,797.
Turnover
≈ €480,000 estimated
The micro format states no turnover.
Liquidity
2.38 was 1.34 in 2024
Short-term debts fell from €436,622 to €166,573.
Filings
5 annual accounts since 2021
The last five annual accounts were filed 2 to 35 days before the end of the period.
Position in the sector
€236,797
Higher net result than 91% of companies in human health. Sector median €60,071 · 20,751 companies.
Checked score
96
Excellent
Financially stronger than 68% of micro companies in human health (NACE 86)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: < 0.1% across 24,185 companies (NACE 86, micro).
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: < 0.1%
01-2025: < 0.1%● unchanged vs 12-2024
02-2025: < 0.1%● unchanged vs 01-2025
03-2025: < 0.1%● unchanged vs 02-2025
04-2025: < 0.1%● unchanged vs 03-2025
05-2025: < 0.1%● unchanged vs 04-2025
06-2025: < 0.1%● unchanged vs 05-2025
07-2025: < 0.1%● unchanged vs 06-2025
08-2025: 0.1%▲ +0.1 percentage points vs 07-2025
09-2025: < 0.1%▼ -0.1 percentage points vs 08-2025
10-2025: < 0.1%● unchanged vs 09-2025
11-2025: < 0.1%● unchanged vs 10-2025
12-2025: < 0.1%● unchanged vs 11-2025
01-2026: < 0.1%● unchanged vs 12-2025
02-2026: < 0.1%● unchanged vs 01-2026
03-2026: < 0.1%● unchanged vs 02-2026
04-2026: 0.1%▲ +0.1 percentage points vs 03-2026
05-2026: 0.1%● unchanged vs 04-2026
06-2026: 0.1%● unchanged vs 05-2026
07-2026: 0.1%● unchanged vs 06-2026
08-2026: 0.2%▲ +0.1 percentage points vs 07-2026highest value
09-2026: 0.1%▼ -0.1 percentage points vs 08-2026
10-2026: < 0.1%▼ -0.1 percentage points vs 09-2026lowest value
11-2026: < 0.1%● unchanged vs 10-2026lowest value
Financial strengthStrong
Score breakdown
lowers risk
Sector: Human health activities (NACE 86)
Liquidity: current ratio 2.38, cash €333,763
Size: total assets €408,370
Equity €241,797 (59.2% of total assets)
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 47% of them on solvency, 63% on liquidity, 80% on profitability and 80% on growth.
The bankruptcy probability was computed on 09-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 26,972 companies had the same profile as IM Medic has now. Each dot stands for 68 companies, two years later.
94.9%
were still trading
3.4%
stopped another way
1.6%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
The bankruptcy probability of IM Medic itself is lower: < 0.1% within 12 months. It rests on far more data about IM Medic than the profile alone.
Test of the method
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 26,972 companies, not a prediction for IM Medic. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €23,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 2.38 (1.34 in 2024), above the usual 1.5. Short-term debt is 40.8% and cash 81.7% of total assets. 40.8% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
5 signals, none raises the risk
Five signals.
lowers riskneutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 26-06-2026, 35 days ahead of the deadline.
NBB · 5 filingsDeviation from the deadline
2025
35 days early
2024
2 days early
2023
5 days early
2022
28 days early
2021
32 days early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 5 accounts on average 20 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 3 July (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
10-11-2026 today31-12-2026 year end31-07-2027 deadline
Recent changes
Registered office moved from Zandhoven to Halle-Zoersel
New registered office: Wandelweg 67, 2980 Halle-Zoersel · Previous registered office: De Bergen 54, 2240 Zandhoven · Board meeting of 21-06-2024 · Gazette deed
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0768434889
Incorporation
Founding capital of €5,000, 50 shares · Founder: MARIEN Ilke Renata Elisabeth · Appointment: MARIEN Ilke Renata Elisabeth (statutory director) · published on 19-05-2021 · Gazette deed
First establishment
Wandelweg 67, Zoersel
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| IM Medic Zoersel | €408,370 | €316,375 | 59.2% | - |
| Dr. Mohab Omer, anesthésie Schilde | €429,072 | €282,372 | 2.1% | - |
| B Beauty Arlon | €403,358 | €318,875 | 86.0% | - |
| Marie MOUTHUY Frasnes-lez-Anvaing | €407,424 | €319,467 | 45.4% | - |
| ORTHERO Ninove | €405,613 | €331,765 | 0.9% | - |
| EYEFUNDUS Hamont-Achel | €385,452 | €344,334 | 38.3% | - |
| EPC MEDICAL Uccle | €362,516 | €336,891 | 35.0% | - |
These companies have the same main activity as IM Medic: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €363,000 and €429,000, founded in 2021.
Official details
Source: KBO- Status
- Active since 17-05-2021Normal situation
- Activity
- Specialist medical practiceNACE 86220
- Establishment unit
- 2.317.337.7202980 Zoersel, since 17-05-2021
- Financial year end
- 31 December
- Peppol
- Reachable since 24-11-2023
Annual accounts 2025
- €408,370▼ 32.4%
- Filing
- Filed on 26-06-2026, 35 days before the end of the filing period
Insights on IM Medic
IM Medic files the micro format. That format states no turnover. The gross margin rose from €167,133 in 2021 to €316,375 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about IM Medic
- What is the company number of IM Medic?
- The company number of IM Medic is 0768.434.889. The VAT number is the same number with BE in front: BE 0768.434.889.
- Where is IM Medic based?
- The registered office is at Wandelweg 67, 2980 Zoersel.Company details
- What does IM Medic do?
- According to the KBO register, the main activity is specialist medical practice (NACE 86220).
- What is the legal form of IM Medic?
- IM Medic is a private limited company (BV).
- When was IM Medic founded?
- IM Medic was founded on 17-05-2021.
- Is IM Medic still active?
- Yes, IM Medic is an active enterprise in the KBO register.
- What is the turnover of IM Medic?
- The turnover in financial year 2025 is ≈ €480,000. This figure is estimated from the gross margin of €316,375 and 30 comparable companies (NACE 86220). It probably lies between €430,000 and €660,000.Financials
- Is IM Medic profitable?
- In financial year 2025, IM Medic made a profit of €236,797.
- Where can I find the annual accounts of IM Medic?
- IM Medic filed 5 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of IM Medic due?
- IM Medic must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.